ðɛɹˌɑːɹ nˈoʊ dɹˈʌɡz kˈɜːɹəntli ɐpɹˈuːvd tə tɹˈiːt kɔːɹdˈoʊmə, haʊˈɛvɚɹ ɐ klˈɪnɪkəl tɹˈaɪəl kəndˈʌktᵻd ɪn ˈɪɾəli jˈuːzɪŋ ɐ tˈaɪɹəsˌaɪn kˈɪneɪs ɪnhˈɪbɪɾɚɹ ɪmˈætɪnˌɪb dˈɛmənstɹˌeɪɾᵻd ɐ mˈɑːdɪst ɹᵻspˈɑːns ɪn sˌʌm kɔːɹdˈoʊmə pˈeɪʃənts.
There are no drugs currently approved to treat chordoma, however a clinical trial conducted in Italy using a tyrosine kinase inhibitor imatinib demonstrated a modest response in some chordoma patients.